Pyridoxamine is a synthetic derivative of vitamin B6 and a member of the pyridoxamine class, utilized as an adjunctive therapeutic agent in the management of multiple myeloma and other hematologic malignancies.… Read more
Pyridoxamine is a synthetic derivative of vitamin B6 and a member of the pyridoxamine class, utilized as an adjunctive therapeutic agent in the management of multiple myeloma and other hematologic malignancies. By inhibiting 5'-nucleotidase, this compound helps suppress tumor cell proliferation and encourages apoptosis in malignant plasma cells. Laboratories supporting the development and monitoring of this drug rely on high-quality reference standards, including the parent compound Pyridoxamine Dihydrochloride and its critical metabolite Pyridoxamine-5'-phosphate. Furthermore, stable isotope labelled compounds such as Pyridoxamine-d3 and Pyridoxamine-d5 dihydrochloride are indispensable tools in modern analytical chemistry. These reference materials are vital for conducting precise impurity profiling, method validation, and rigorous quality control, ensuring that pharmaceutical manufacturing processes meet regulatory standards for efficacy and safety. By providing accurate benchmarks, these standards enable researchers to maintain consistency in quantitative analysis throughout the drug development lifecycle.